These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23025155)

  • 1. [Duodenal levodopa infusion for advanced Parkinson's disease in Finland 2006-2010].
    Pursiainen V; Pekkonen E
    Duodecim; 2012; 128(16):1707-15. PubMed ID: 23025155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation.
    Wider C; Russmann H; Villemure JG; Robert B; Bogousslavsky J; Burkhard PR; Vingerhoets FJ
    Arch Neurol; 2006 Jul; 63(7):951-5. PubMed ID: 16831963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience with continuous levodopa enteral infusion (Duodopa(®)) in patients with advanced Parkinson's disease in a secondary level hospital].
    Santos-García D; Macías M; Llaneza M; Fuster-Sanjurjo L; Echarri-Piudo A; Belmonte S; Blanco S
    Neurologia; 2010; 25(9):536-43. PubMed ID: 21093702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term exposure to duodenal levodopa/carbidopa infusion therapy improves quality of life in relation especially to mobility, activities of daily living, and emotional well-being.
    Santos-García D; Sanjurjo LF; Macías M; Llaneza M; Carpintero P; de la Fuente-Fernández R
    Acta Neurol Scand; 2012 Mar; 125(3):187-91. PubMed ID: 21615352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
    Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
    Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.
    Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.
    Antonini A; Mancini F; Canesi M; Zangaglia R; Isaias IU; Manfredi L; Pacchetti C; Zibetti M; Natuzzi F; Lopiano L; Nappi G; Pezzoli G
    Neurodegener Dis; 2008; 5(3-4):244-6. PubMed ID: 18322402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duodopa pump treatment in patients with advanced Parkinson's disease.
    Karlsborg M; Korbo L; Regeur L; Glad A
    Dan Med Bull; 2010 Jun; 57(6):A4155. PubMed ID: 20515603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jejunal levodopa infusion in long-term DBS patients with Parkinson's disease.
    Klostermann F; Jugel C; Marzinzik F
    Mov Disord; 2011 Oct; 26(12):2298-9. PubMed ID: 21714008
    [No Abstract]   [Full Text] [Related]  

  • 10. Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease.
    Devos D;
    Mov Disord; 2009 May; 24(7):993-1000. PubMed ID: 19253412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.
    Piboolnurak P; Lang AE; Lozano AM; Miyasaki JM; Saint-Cyr JA; Poon YY; Hutchison WD; Dostrovsky JO; Moro E
    Mov Disord; 2007 May; 22(7):990-7. PubMed ID: 17443692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
    Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
    Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum vitamin B(12) and folate levels in Parkinson's disease patients treated with duodenal levodopa infusion.
    Santos-García D; Macías M; Llaneza M; Grande M; de la Fuente-Fernández R
    Mov Disord; 2011 Feb; 26(3):558-9. PubMed ID: 20960480
    [No Abstract]   [Full Text] [Related]  

  • 14. Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease.
    Calandrella D; Romito LM; Elia AE; Del Sorbo F; Bagella CF; Falsitta M; Albanese A
    Neurology; 2015 Apr; 84(16):1669-72. PubMed ID: 25809301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's disease.
    Evidente VG; Premkumar AP; Adler CH; Caviness JN; Driver-Dunckley E; Lyons MK
    Acta Neurol Scand; 2011 Sep; 124(3):211-4. PubMed ID: 20969559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease: recent development in therapies for advanced disease with a focus on deep brain stimulation (DBS) and duodenal levodopa infusion.
    Sydow O
    FEBS J; 2008 Apr; 275(7):1370-1376. PubMed ID: 18279380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome.
    Antonini A; Isaias IU; Canesi M; Zibetti M; Mancini F; Manfredi L; Dal Fante M; Lopiano L; Pezzoli G
    Mov Disord; 2007 Jun; 22(8):1145-9. PubMed ID: 17661426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
    Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease.
    Syed N; Murphy J; Zimmerman T; Mark MH; Sage JI
    Mov Disord; 1998 Mar; 13(2):336-8. PubMed ID: 9539350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive improvement after duodenal levodopa infusion in cognitively impaired Parkinson's disease patients.
    Sánchez-Castañeda C; Campdelacreu J; Miró J; Juncadella M; Jaumà S; Calopa M
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):250-1. PubMed ID: 19887096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.